Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of RAY1225 in adults with overweight or obesity
CTR20251977Phase 3Active
- Sponsor
- Raynovent Biotech
- Start
- Jun 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of RAY1225, sponsored by Raynovent Biotech. Started Jun 2025; status: active.
02
Drugs
RAY1225
Beyond the preview
Go deeper on CTR20251977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251977.